Arnogene: A Phosphocalcic Study in Dialysis
NCT00858260 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200
Last updated 2009-09-04
Summary
Searching for high morbi-mortality risk Klotho variants in dialysis patients
Conditions
- Dialysis
Interventions
- GENETIC
-
blood sample
Searching for Klotho variants in DNA
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Principal Investigators
-
FOUQUE Denis, MD · Hospices Civils de Lyon
-
LEGRAND Eric, MD · CH Annonay
-
KAARASLAN Huseyin, MD · CH Bourgoin Jallieu
-
ABOKASEM Ayman, MD · CH Chalon/saône
-
LATAILLADE Claire Dominique, MD · CH Sallanches
-
KUENTZ François, MD · Centre Dialyse eaux claires
-
HACHACHE Toufic, MD · CHU Grenoble - La Tronche
-
LEITIENNE Philippe, MD · Hospices Civils de Lyon
-
ARKOUCHE Walid, MD · AURAL - Lyon
-
HEYANI Ahmed, MD · CH MACON
-
HANNOUN Jacques, MD · CH Villefranche/saône
-
COMBARNOUS François, MD · Clinique du Tonkin VILLEURBANNE
-
MAUREAUGANDRY Xavier, MD · AGDUC - Montélimar
-
SIRAJEDINE Mohamed, MD · CH ROMANS/ISERE
-
JEAN Ahmed, MD · Centre du Rein - Tassin la demi lune
-
DENICOLA Cora, MD · Calydial - CH Viennes
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-11-30
- Completion
- 2009-02-28
Countries
- France
Study Locations
More Related Trials
-
Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients.
NCT01982864 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Evaluate Effectiveness of Aranesp®
NCT00117130 ·Status: COMPLETED ·Phase: PHASE4
-
NI-0401 in Patients With Acute Renal Allograft Rejection
NCT00805909 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Aranesp® Monthly Preference Study - 2
NCT00117078 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
NCT00542815 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia
NCT00542386 ·Status: COMPLETED ·Phase: PHASE3
-
Constitutive Study of a Serum Bank and Plasma Bank of Healthy Subjects Comparators to Dialysis Subjects (SPSSCD)
NCT05122845 ·Status: COMPLETED ·Phase: NA
-
Study of Haemodialysis Patients Switching From Aranesp to Biosimilar
NCT02191150 ·Status: COMPLETED
-
Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease Using the Dialysis Anemia TReatmenT Model
NCT05936021 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Compare Efficacy and Safety of Nanogen's Darbepoetin Alfa With Aranesp® (Amgen) in the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis (CKD)
NCT05585645 ·Status: COMPLETED ·Phase: PHASE3
-
Study of WAL0921 in Patients With Glomerular Kidney Diseases
NCT06466135 ·Status: RECRUITING ·Phase: PHASE2
-
A Multi-Center, Open-Label Study
NCT01468259 ·Status: WITHDRAWN ·Phase: PHASE1
-
Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects
NCT01459250 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)
NCT04235621 ·Status: TERMINATED
-
Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
NCT03256838 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
NCT00530114 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis
NCT02000219 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis
NCT05636891 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)
NCT00886353 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease
NCT06350123 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3113593 in Participants With Chronic Kidney Disease
NCT02604160 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis
NCT01739660 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects
NCT04958187 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction
NCT00483600 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of Pentoxifylline on Chronic Kidney Disease
NCT00155246 ·Status: COMPLETED ·Phase: PHASE4